Repeated administration of tacrine to normal rats: Effects on cholinergic, glutamatergic, and gabaergic receptor subtypes in rat brain using receptor autoradiography

Neurochemistry International

Volumn 31, Issue 5, 1997, Pages 693-703

  Sihver, Wiebke ^a   Günther, Peter ^a   Schliebs, Reinhard ^a   Bigl, Volker ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; CHOLINE; CHOLINERGIC RECEPTOR; GLUTAMATE RECEPTOR; KAINIC ACID RECEPTOR; MUSCARINIC M2 RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE; TACRINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; CHOLINERGIC ACTIVITY; COGNITION; CONTROLLED STUDY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION;

ANIMALIA;

EID: 17144469568     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(97)00010-7     Document Type: Article

References (51)

1. Adem, A., Mohammed, A. H., Winblad, B. and Henriksson, B. E. (1994) A novel anticholinesterase THB013: biochemical and behavioural studies. J. Neural Transm. [P-D Sect.] 8, 139-148.
2. Albin, R. L., Young, A. B. and Penney, J. B. (1988) Tetrahydro-9-aminoacridine (THA) interacts with the phencyclidine (PCP) receptor site. Neurosci. Lett. 88, 303-306.
3. Alonso, R., Kan, J. P., Worms, P. et al. (1990) Effects of repeated administration of tetrahydroaminoacridine (THA) on muscarinic receptor subtypes in the rat brain. Neurochem. Int. 17, 457-465.
4. Bierer, L. M., Haroutunian, V., Gabriel, S., Knott, P. J., Carlin, L. S., Purohit, D. P., Perl, D. P., Schmeidler, J., Kanof, P. and Davis, K. (1995) Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J. Neurochem. 64, 749-760.
5. Clarke, P. B. S., Reuben, M. and El-Bizri, H. (1994) Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum. Br. J. Pharmacol. 111, 695-702.
6. Davenport, C. J., Monyer, H. and Choi, D. W. (1988) Tetrahydroaminoacridine selectively attenuates NMDA receptor mediated neurotoxicity. Eur. J. Pharmacol. 154, 73-78.
7. Dawson, R. M. (1990) Reversibility of the inhibition of acetylcholinesterase by tacrine. Neurosci. Lett. 118, 85-87.
8. Decker, M. W. and McGaugh, J. L. (1991) The role of interactions between cholinergic system and other neuromodulatory systems in learning and memory. Synapse 7, 151-178.
9. Drukarch, B., Kits, K. S., Van der Meer, E. G., Lodder, G. C. and Stoof, J. C. (1987) 9-Amino-1,2,3,4-tetrahydroaminoacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current. Eur. J. Pharmacol. 141, 153-157.
10. Dunnett, S. B., Everitt, B. J. and Robbins, T. W. (1991) The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions. Trends Neurosci. 14, 494-501.
11. Dutar, P., Bassant, M. H. and Lamour, Y. (1990) Effects of tetrahydro-9-aminoacridine on cortical and hippocampal neurons in the rat: an in vivo and in vitro study. Brain Res. 527, 32-40.
12. Flynn, D. D. and Mash, D. C. (1989) Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine. J. Pharmacol. Exp. Ther. 250, 573-581.
13. Freeman, S. E. and Dawson, R. M. (1991) Tacrine: a pharmacological review. Progr. Neurobiol. 36, 257-277.
14. Halliwell, J. V. and Grove, E. A. (1989) 9-Amino-1,2,3,4-tetrahydroacridine (THA) blocks agonist-induced potassium conductance in rat hippocampal neurones. Eur. J. Pharmacol. 163, 369-372.
15. Heilbronn, E. (1961) Inhibition of cholinesterase by tetrahydroacridine. Acta Chem. Scand. 15, 1386-1390.
16. Hershkowitz, N. and Rogawski, M. A. (1991) Tetrahydroaminoacridine block of N-methyl-D-aspartate-activated cation channels in cultured hippocampal neurons. Mol. Pharmacol. 39, 592-598.
17. Hunter, A. J., Murray, T. K., Jones, J. A., Cross, A. J. and Green, A. R. (1989) The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro. Br. J. Pharmacol. 98, 79-86.
18. Kawashima, K., Sato, A., Yoshizawa, M., Fujii, T., Fujimoto, K. and Suzuki, T. (1994) Effects of centrally acting cholinesterase inhibitors tetrahydroaminoacridine and E2020 on the basal concentration of extracellular acetylcholine in the hippocampus of freely moving rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 350, 523-528.
19. Kiefer-Day, J. S., Abdallah, E. A. M., Forray, C., Lee, N. H., Kim, O. N. and El-Fakahany, E. E. (1993) Effects of tacrine on brain muscarinic-receptor-mediated second-messenger signals. Pharmacology 47, 98-110.
20. Kumar, A. and Schliebs, R. (1992) Postnatal development of cholinergic receptors, protein kinase C and dihydropyridine-sensitive calcium antagonist binding in rat visual cortex. Effect of visual deprivation. Int. J. Devl. Neurosci. 10, 491-504.
21. A and benzodiazepine receptors in individual layers of rat visual cortex and the effect of visual deprivation. Neurochem. Int. 23, 99-106.
22. Kumar, A., Schliebs, R. and Bigl, V. (1994) Postnatal development of NMDA, AMPA, and kainate receptors in individual layers of rat visual cortex and the effect of monocular deprivation. Int. J. Devl. Neurosci. 12, 31-41.
23. McNally, W., Roth, M., Young, R., Bockbrader, H. and Chang, T. (1989) Quantitative whole-body autoradiographic determination of tacrine tissue distribution in rats following intravenous or oral dose. Pharmaceut. Res. 6, 924-930.
24. Messamore, E., Warpman, U., Ogane, N. and Giacobini, E. (1993) Cholinesterase inhibitor effects on extracellular acetylcholine in rat cortex. Neuropharmacology 32, 745-750.
25. Musilková, J. and Tucek, S. (1991) The binding of cholinesterase inhibitors tacrine (tetrahydroaminoacridine) and 7-methoxytacrine to muscarinic acetylcholine receptors in rat brain in the presence of eserine. Neurosci. Lett. 125, 113-116.
26. Nielsen, J. A., Mena, E. E., Williams, I. H., Nocerini, M. R. and Liston, D. (1989) Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes. Eur. J. Pharmacol. 173, 53-64.
27. Nilsson, L., Adem, A., Hardy, J., Winblad, B. and Nordberg, A. (1987) Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors?. J. Neural. Transm. 70, 357-368.
28. Nordberg, A. (1992) Neuroreceptor changes in Alzheimer disease. Cerebrovasc. Brain Met. Rev. 4, 303-328.
29. O'Connell, A., Early, B. and Leonhard, B. E. (1994) The neuroprotective effect of tacrine on trimethyltin induced memory and muscarinic receptor dysfunction in the rat. Neurochem. Int. 25, 555-566.
30. 2 muscarinic receptors. Neurosci. Lett. 88, 281-285.
31. Perry, E. K., Smith, C. J., Court, J. A., Bonham, J. R., Rodway, M. and Atack, J. R. (1988) Interaction of 9-amino-1,2,3,4-tetrahydroaminoacridine (THA) with human cortical nicotinic and muscarinic receptor binding in vitro. Neurosci. Lett. 91, 211-216.
32. 1 muscarinic receptors. Mol. Pharmacol. 35, 652-660.
33. Rogawski, M. A. (1987) Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons. Eur. J. Pharmacol. 142, 169-172.
34. Roßner, S., Schliebs, R. and Bigl, V. (1994) Ibotenic acid lesion of nucleus basalis magnocellularis differentially affects cholinergic, glutamatergic and GABAergic markers in cortical rat brain regions. Brain Res. 668, 85-99.
35. Roßner, S., Schliebs, R., Perez-Polo, J. R., Wiley, R. G. and Bigl, V. (1995a) Differential changes in cholinergic markers from selected brain regions after specific immunolesion of rat cholinergic basal forebrain system. J. Neurosci. Res. 40, 31-43.
36. Roßner, S., Schliebs, R. and Bigl, V. (1995b) 192IgG-saporin-induced immunotoxic lesions of cholinergic basal forebrain system differentially affect glutamatergic and GABAergic markers in cortical rat brain regions. Brain Res. 696, 165-176.
37. Roßner, S., Schliebs, R., Härtig, W. and Bigl, V. (1995c) 192IgG-saporin-induced selective lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus. Brain Res. Bull. 38, 371-381.
38. Schauf, C. L. and Sattin, A. (1987) Tetrahydroaminoacridine blocks potassium channels and inhibits sodium inactivation in Myxicola. J. Pharmacol. Exp. Ther. 243, 609-613.
39. Schliebs, R., Feist, T., Roßner, S. and Bigl, V. (1994) Receptor function in rat brain regions after lesion of nucleus basalis. J. Neural Transm., Suppl. 44, 195-208.
40. Schwartz, J. C., Cortes, C. L., Rose, C., Quach, T. T. and Pollard, H. (1983) Adaptive changes of neurotransmitter receptor mechanisms in the central nervous system. Progr. Brain Res. 58, 117-129.
41. Steckler, T. and Sahgal, A. (1995) The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour. Behav. Brain Res. 67, 165-199.
42. Stevens, D. R. and Cotman, C. W. (1987) Excitatory actions of tetrahydro-9-aminoacridine (THA) on hippocampal pyramidal neurons. Neurosci. Lett. 79, 301-305.
43. Suzuki, T., Nonaka, H., Fujimoto, K. and Kawashima, K. (1994) Tacrine increases stimulation-evoked acetycholine release from rat hippocampal slices. Jpn. Pharmacol. 65, 337-342.
44. Szilagyi, M. and Lau, W.-M. (1993) Interaction of tacrine at M1 and M2 cholinoceptors in guinea pig brain. Pharmacology 47, 223-229.
45. Vivas, N. M., Marmol, F., Salles, J., Badia, A. and Diersen, M. (1995) Action on noradrenergic transmission of an anticholinesterase - 9-Amino-1,2,3,4-tetrahydroacridine. Neuropharmacology 34, 367-375.
46. Vorobjev, V. S. and Sharonova, I. N. (1994) Tetrahydroaminoacridine blocks and prolongs NMDA receptor-mediated responses in a voltage-dependent manner. Eur. J. Pharmacol. 253, 1-8.
47. Wagstaff, A. J. and McTavish, D. (1994) Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease. Drugs and Aging 4, 510-540.
48. Wang, S.-J., Huang, C.-C. and Gean, P.-W. (1995) Tetrahydro-9-aminoacridine presynaptically inhibits glutamatergic transmission in the rat amygdala. Brain Res. Bull. 37, 325-327.
49. Warpman, U., Zhang, X. and Nordberg, A. (1996) Effect of tacrine on in vivo release of dopamine and its metabolites in the striatum of freely moving rats. J. Pharmacol. Exp. Ther. 277, 917-922.
50. Xiao, W.-B., Nordberg, A. and Zhang, X. (1993) Effect of in vivo microdialysis of 1,2,3,4-tetrahydro-9-aminoacridine (THA) on the extracellular concentration of acetylcholine in the striatum of anesthetized rats. J. Pharmacol. Exp. Ther. 265, 759-764.
51. Zilles, K. (1985) The Cortex of the Rat. Astereotaxic Atlas. Springer, Berlin.